Want to see HK:0775 full AI Analyst Report?
CK Life Sciences International (Holdings), Inc. (0775) Financial Statements
CK Life Sciences International (Holdings), Inc. Financial Overview
CK Life Sciences International (Holdings), Inc.'s market cap is currently $4.71B. The company's EPS TTM is $-0.01; its P/E ratio is -73.13; and it has a dividend yield of 1.01%. CK Life Sciences International (Holdings), Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.41B | $ 5.52B | $ 5.32B | $ 5.28B | $ 5.40B |
| Gross Profit | $ 785.38M | $ 1.69B | $ 1.64B | $ 1.63B | $ 1.63B |
| Operating Income | $ -135.28M | $ 783.06M | $ 223.85M | $ 219.51M | $ 233.69M |
| EBITDA | $ -49.42M | $ 488.35M | $ 624.75M | $ 598.85M | $ 574.15M |
| Net Income | $ -188.45M | $ -126.55M | $ 17.25M | $ 131.96M | $ 162.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 603.07M | $ 571.21M | $ 676.16M | $ 704.13M | $ 902.47M |
| Total Assets | $ 11.84B | $ 10.79B | $ 11.25B | $ 11.27B | $ 11.73B |
| Total Debt | $ 6.62B | $ 6.10B | $ 5.93B | $ 5.95B | $ 6.21B |
| Net Debt | $ 6.02B | $ 5.55B | $ 5.27B | $ 5.25B | $ 5.32B |
| Total Liabilities | $ 7.99B | $ 7.28B | $ 7.06B | $ 7.11B | $ 7.23B |
| Stockholders' Equity | $ 3.78B | $ 3.51B | $ 4.19B | $ 4.16B | $ 4.50B |
| Cash Flow | |||||
| Free Cash Flow | $ -277.76M | $ 157.00M | $ 222.35M | $ 146.69M | $ 206.33M |
| Operating Cash Flow | $ -32.77M | $ 353.53M | $ 514.18M | $ 363.66M | $ 423.57M |
| Investing Cash Flow | $ -362.68M | $ -96.64M | $ -67.96M | $ -22.12M | $ -257.88M |
| Financing Cash Flow | $ 428.57M | $ -341.98M | $ -477.95M | $ -515.34M | $ -220.08M |
Currency in HKD